Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses. (2018)
Attributed to:
Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/23120541.00119-2017
PubMed Identifier: 29750142
Publication URI: http://europepmc.org/abstract/MED/29750142
Type: Journal Article/Review
Volume: 4
Parent Publication: ERJ open research
Issue: 2
ISSN: 2312-0541